Clinical trial
Phase 2 Study of S-892216 in Participants Infected With SARS-CoV-2
NCT06928051 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of S-892216 in Participants Infected With SARS-CoV-2
- Lead sponsor
- Shionogi
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 6, 2025
- Completion date
- September 22, 2025
- Enrollment
- 282 (actual)
- Sites
- 57
Conditions
As the registry lists them; a condition with its own page is linked.